Evidence map›Paper›PMID 34797991›Full record

ArticleLupus2021

Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous.

Mitra Moazzami, Patricia Katz, Dennisse Bonilla, Lisa Engel, Jiandong Su, Pooneh Akhavan, Nicole Anderson, Oshrat E Tayer-Shifman, Dorcas Beaton, Zahi Touma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lupus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mitra MoazzamiDepartment of Medicine, 43989The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Patricia KatzDepartment of Medicine and Health Policy, 8785University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-8146-2519
Dennisse BonillaDivision of Rheumatology, Department of Medicine, Toronto Western Hospital-Lupus Clinic, 7989University Health Network, Toronto, ON, Canada.
Lisa EngelDepartment of Occupational Therapy, College of Rehabilitation Sciences, Rady Faculty of Health Sciences, 8664University of Manitoba, Winnipeg, MB, Canada.
Jiandong SuCentre for Prognosis Studies in the Rheumatic Diseases, 7989University Health Network, Toronto, ON, Canada.
Pooneh AkhavanDivision of Rheumatology, Department of Medicine, Mount Sinai Hospital, 12366University of Toronto Faculty of Medicine, Toronto, ON, Canada.
Nicole AndersonDivision of Rheumatology, Department of Medicine, Toronto Western Hospital-Lupus Clinic, 7989University Health Network, Toronto, ON, Canada.
Oshrat E Tayer-ShifmanRheumatology Service, 37253Meir Medical Center, Kfar-Saba, Israel.
Dorcas BeatonHealth Measurement, St. Michael's Hospital, University of Toronto, 7966Institute for Work and Health, Toronto, ON, Canada.
Zahi ToumaDivision of Rheumatology, Department of Medicine; Toronto Western Hospital-Lupus Clinic; Institute of Health Policy, Management and Evaluation, 7938University of Toronto, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-5177-2076

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe evaluation of Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive test (CAT) in adults with systemic lupus erythematous (SLE) is an emerging field of research. We aimed to examine the test-retest reliability and construct validity of the PROMIS CAT in a Canadian cohort of patients with SLE.

methodsTwo hundred twenty-seven patients completed 14 domains of PROMIS CAT and seven legacy instruments during their clinical visits. Test-retest reliability of PROMIS was evaluated 7-10 days from baseline using intraclass correlation coefficient (ICC (2; 1)). The construct validity of the PROMIS CAT domains was evaluated against the commonly used legacy instruments, and also in comparison to disease activity and disease damage using Spearman correlations. A multitrait-multimethod matrix (MMM) approach was used to further assess construct validity comparing selected 10 domains of PROMIS and SF-36 domains.

resultsModerate to excellent reliability was found for all domains (ICC [2;1] ranging from lowest, 0.66 for Sleep Disturbance and highest, 0.93 for the Mobility domain). Comparing seven legacy instruments with 14 domains of PROMIS CAT, moderate to strong correlations (0.51-0.91) were identified. The average time to complete all PROMIS CAT domains was 11.7 min. The MMM further established construct validity by showing moderate to strong correlations (0.55-0.87) between select PROMIS and SF-36 domains; the average correlations from similar traits (convergent validity) were significantly greater than the average correlations from different traits.

conclusionsThese results provide evidence on the reliability and validity of PROMIS CAT in SLE in a Canadian cohort.

Indexed as

Lupus Erythematosus, DiscoidLupus Erythematosus, SystemicCanadaErythemaHumansInformation SystemsPatient Reported Outcome MeasuresReproducibility of ResultsSurveys and QuestionnairesLupuspatient-reported outcomesPROMIS

Identifiers

PMID34797991
PMCPMC8649426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.